West Island Brands Inc. (WIBFF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
West Island Brands Inc. (WIBFF) trades at $0.00 with AI Score 57/100 (Grade B). West Island Brands Inc. operates in the medical marijuana sector, offering products like IONIC MIST, a spray designed to neutralize cannabis smoke odors. Market cap: $60,061, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for WIBFF: WIBFF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates WIBFF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
WIBFF: 2/4 perspectives are bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →West Island Brands Inc. (WIBFF) Healthcare & Pipeline Overview
West Island Brands Inc. is a Toronto-based healthcare company specializing in the medical marijuana business, notably offering IONIC MIST for cannabis smoke odor neutralization. Operating within the evolving cannabis market, the company navigates the OTC Other tier, focusing on niche product development amidst a dynamic regulatory environment.
What Is the Investment Thesis for WIBFF?
West Island Brands Inc. operates in the medical marijuana sector, with its flagship product, IONIC MIST, targeting a niche within the broader cannabis consumer market by neutralizing smoke odors. The company's current financial profile indicates a market capitalization of 60K, reflecting its very small scale. Profitability metrics show a significant challenge, with a profit margin of -228.7% and a gross margin of -113.0%, underscoring ongoing operational losses. The stock's high beta of 8.56 suggests substantial volatility relative to the broader market. As an OTC Other tier listing, the company faces inherent risks related to limited liquidity and disclosure. Future value drivers hinge on the company's ability to achieve positive gross and profit margins through increased sales of IONIC MIST and potential expansion into other cannabis-related products. Growth catalysts include successful market penetration for IONIC MIST, securing additional funding to support operations, and navigating the evolving regulatory landscape for cannabis and hemp products to unlock new market opportunities. However, the significant negative margins and small market cap present considerable operational and financial hurdles.
Based on FMP financials and quantitative analysis
WIBFF Key Highlights
- Market capitalization stands at $0.00B, indicating a micro-cap status and potentially limited institutional investor interest.
- Profit margin of -228.7% highlights substantial net losses relative to revenue, signaling significant operational challenges.
- Gross margin of -113.0% suggests that the cost of goods sold exceeds revenue, indicating fundamental issues in product pricing or production efficiency.
- A beta of 8.56 implies extreme volatility, with the stock historically moving significantly more than the overall market.
- The company does not pay a dividend, consistent with its current financial performance and growth stage.
Who Are WIBFF's Competitors?
WIBFF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| NPNKF Nippon Shinyaku Co., Ltd. | $32.75 | +4.30% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are WIBFF's Key Strengths?
- Unique product offering with IONIC MIST addressing a specific consumer need in the cannabis market.
- Operates in the growing market for cannabis and hemp products, offering potential expansion avenues.
- Long-standing incorporation since 2007, indicating resilience and adaptability.
- Positioned within the medical marijuana business, a segment with increasing acceptance and legalization.
What Are WIBFF's Weaknesses?
- Very small market capitalization ($0.00B), suggesting limited resources and market influence.
- Significant negative profit margin (-228.7%) and gross margin (-113.0%) indicating severe profitability challenges.
- OTC Other tier listing, which typically implies lower transparency and higher risk for investors.
- High beta of 8.56, indicating extreme stock price volatility.
What Could Drive WIBFF Stock Higher?
- Successful securing of additional funding could stabilize operations and support growth initiatives.
- Achievement of positive gross margins and a clear path towards profitability would signal improved financial health.
- Effective navigation of the evolving regulatory landscape for cannabis and hemp products to unlock new market opportunities.
- Expansion of IONIC MIST distribution channels or market penetration in new legal cannabis markets.
- Introduction of new, complementary cannabis-related ancillary products to diversify revenue streams.
What Are the Key Risks for WIBFF?
- Financial-distress signal — its Altman Z-Score of -7.04 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-99.7%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Significant negative profit margin (-228.7%) and gross margin (-113.0%) indicating severe and persistent operational losses.
- OTC Other tier listing and unknown disclosure status present high risks related to transparency and liquidity.
- Inability to secure necessary funding to sustain operations and invest in growth initiatives.
- Intense competition in the cannabis ancillary market could limit market share and pricing power for IONIC MIST.
- Adverse changes in cannabis regulatory policies could negatively impact market access or operational costs.
What Are the Growth Opportunities for WIBFF?
- **Expansion of IONIC MIST Market Penetration:** West Island Brands Inc. has the opportunity to significantly expand the market penetration of its IONIC MIST product. As the cannabis market continues to grow and normalize across various regions, the demand for ancillary products that enhance the user experience, such as odor neutralizers, is likely to increase. By targeting both medical and recreational cannabis users through diverse distribution channels, including dispensaries, online retail, and specialty stores, the company can capture a larger share of this growing segment. The market for cannabis accessories and related consumer goods is projected to expand, offering a favorable environment for IONIC MIST to gain traction and establish itself as a leading solution in its niche.
- **Product Line Diversification within Cannabis Ancillaries:** Beyond IONIC MIST, West Island Brands Inc. could explore diversification into other cannabis-related ancillary products. This could include developing new solutions for cannabis storage, consumption accessories, or other complementary items that cater to the evolving needs of cannabis consumers. Leveraging its understanding of the cannabis market and consumer preferences, the company could identify unmet needs and introduce innovative products. This strategy would broaden its revenue streams, reduce reliance on a single product, and allow it to capture a larger share of the expanding cannabis consumer packaged goods market, which continues to present new opportunities for specialized offerings.
- **Strategic Partnerships and Distribution Agreements:** Forming strategic partnerships with established cannabis producers, distributors, or retail chains presents a significant growth opportunity. Collaborating with licensed producers could integrate IONIC MIST into broader product offerings or distribution networks, immediately expanding its reach. Such partnerships could provide access to larger customer bases, more efficient supply chains, and greater marketing resources than the company might achieve independently. These alliances could accelerate market entry into new regions or segments, enhance brand visibility, and potentially lead to economies of scale, driving revenue growth and improving the company's overall market position within the competitive cannabis industry.
- **Geographic Expansion within Legalized Cannabis Markets:** As more jurisdictions legalize medical and/or recreational cannabis, West Island Brands Inc. has the opportunity to expand its operations and product distribution into these new geographic markets. Currently based in Toronto, Canada, the company can leverage its experience in a regulated market to navigate similar frameworks elsewhere. Identifying and entering emerging legal cannabis markets, particularly in North America and potentially Europe, could unlock substantial new customer bases for IONIC MIST. Careful market analysis and compliance with local regulations would be critical, but successful expansion could significantly increase sales volumes and establish the company as an international player in the cannabis ancillary products sector.
- **Focus on Brand Building and Consumer Education:** A significant growth opportunity lies in investing in robust brand building and consumer education initiatives for IONIC MIST. In a rapidly evolving market like cannabis, strong brand recognition and consumer trust are paramount. By clearly communicating the unique benefits and effectiveness of IONIC MIST in neutralizing cannabis smoke odors, West Island Brands Inc. can differentiate itself from competitors and build a loyal customer base. Educational campaigns can highlight the product's value proposition, addressing common concerns among cannabis users and those in their vicinity. A well-executed branding strategy can enhance market visibility, drive consumer demand, and command premium pricing, ultimately contributing to sustainable revenue growth and market leadership in its niche.
What Opportunities Does WIBFF Have?
- Expansion of IONIC MIST's market reach through broader distribution channels as cannabis legalization progresses.
- Diversification into other ancillary cannabis products or services to capture more market share.
- Strategic partnerships with larger cannabis companies to enhance distribution and brand visibility.
- Leveraging the growing consumer acceptance of cannabis products to increase demand for odor-neutralizing solutions.
What Threats Does WIBFF Face?
- Intense competition from existing and new players in the cannabis ancillary products market.
- Evolving and unpredictable regulatory landscape for cannabis, which could impact operations or market access.
- Difficulty in securing adequate funding to sustain operations and achieve profitability.
- Limited liquidity and investor interest due to OTC Other listing and small market cap.
- Potential for new technologies or products that offer superior odor neutralization solutions.
What Are WIBFF's Competitive Advantages?
- Proprietary formulation of IONIC MIST for effective cannabis smoke odor neutralization.
- Early mover advantage in a specific niche within the rapidly expanding cannabis ancillary market.
- Established presence since 2007, providing foundational experience in the evolving cannabis sector.
- Focus on a distinct consumer problem (odor management) that may not be directly addressed by core cannabis product manufacturers.
What Does WIBFF Do?
West Island Brands Inc., incorporated in 2007, is a Canadian company based in Toronto that operates within the medical marijuana business. Initially known as Matica Enterprises Inc., the company underwent a name change to West Island Brands Inc. in October 2021, reflecting its evolving strategic focus. The company's core offering includes IONIC MIST, a specialized spray mist designed to capture and neutralize cannabis smoke odors. This product positions West Island Brands within the broader consumer packaged goods sector, specifically addressing ancillary needs within the growing cannabis and hemp product markets. While the company's primary stated business is medical marijuana, its product, IONIC MIST, caters to a wider audience of cannabis consumers by enhancing the consumption experience through odor management. The company's operational base in Toronto, Canada, places it within a jurisdiction that has established legal frameworks for cannabis, providing a foundation for its business activities. West Island Brands Inc. aims to carve out a niche by addressing practical consumer challenges associated with cannabis use, distinguishing itself through product innovation in the odor neutralization segment. Its journey from Matica Enterprises Inc. to West Island Brands Inc. signifies a strategic pivot or refinement in its market approach, aligning with the burgeoning opportunities within the cannabis industry. The company's continued existence since 2007 indicates a long-standing presence, adapting its business model to market demands and regulatory shifts within the healthcare and consumer product landscapes.
What Products and Services Does WIBFF Offer?
- Engages in the medical marijuana business, focusing on specialized consumer products.
- Develops and offers IONIC MIST, a spray designed to capture and neutralize cannabis smoke odors.
- Operates within the broader consumer packaged goods sector, specifically targeting cannabis and hemp-related needs.
- Aims to enhance the cannabis consumption experience by addressing common issues like odor.
- Was formerly known as Matica Enterprises Inc. before changing its name in October 2021.
- Is incorporated in 2007 and headquartered in Toronto, Canada.
How Does WIBFF Make Money?
- Generates revenue through the sale of its proprietary product, IONIC MIST, to cannabis consumers.
- Focuses on a niche market within the cannabis industry by providing an ancillary solution for odor control.
- Potentially distributes products through various channels, including dispensaries, online platforms, and specialty retailers.
- Relies on product innovation and market acceptance of its specialized mist to drive sales.
What Industry Does WIBFF Operate In?
West Island Brands Inc. operates within the Drug Manufacturers - Specialty & Generic industry, specifically targeting the medical marijuana and broader cannabis consumer market. This sector is characterized by rapid evolution, driven by changing regulatory landscapes, increasing consumer acceptance, and ongoing research into cannabis applications. The global cannabis market is experiencing significant growth, fueled by both medical and recreational legalization trends in various jurisdictions. West Island Brands positions itself by offering an ancillary product, IONIC MIST, which addresses a specific consumer need related to cannabis use – odor neutralization. This places the company in a niche within the larger cannabis ecosystem, competing not only with direct cannabis product manufacturers but also with other ancillary service and product providers. The competitive landscape is fragmented, with numerous players ranging from large licensed producers to smaller, specialized product developers. West Island Brands' success is intrinsically linked to the continued expansion and normalization of the cannabis market, as well as its ability to effectively market and distribute its unique odor-neutralizing solution.
Who Are WIBFF's Key Customers?
- Medical marijuana patients seeking to manage smoke odors in their environment.
- Recreational cannabis users looking for discreet consumption solutions.
- Dispensaries and retail outlets that stock cannabis accessories and related products.
- Individuals concerned with the lingering smell of cannabis smoke in homes or personal spaces.
Company Profile
West Island Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Boris Ivan Ziger. WIBFF has traded publicly since 2015.
How West Island Brands Inc. Is Valued
West Island Brands Inc. carries a market capitalization of 60K, placing it in the micro-cap category. Relative to its peer group, WIBFF's quantitative score of 57/100 is roughly in line with the peer average of 66/100.
ROE -100%Key Financial Metrics
Return on equity for West Island Brands Inc. stands at -99.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -86.6%, showing how much profit it generates from its asset base. Its free cash flow yield is -79.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.03 indicates the company holds enough short-term assets to cover its near-term obligations.
F-Score 3/9Financial Health
West Island Brands Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -7.04 places it in the distress zone, a signal of elevated financial risk.
WIBFF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Unique product offering with IONIC MIST addressing a specific consumer need in the cannabis market.
- Operates in the growing market for cannabis and hemp products, offering potential expansion avenues.
- Long-standing incorporation since 2007, indicating resilience and adaptability.
- Positioned within the medical marijuana business, a segment with increasing acceptance and legalization.
Bear Case
- Very small market capitalization ($0.00B), suggesting limited resources and market influence.
- Significant negative profit margin (-228.7%) and gross margin (-113.0%) indicating severe profitability challenges.
- OTC Other tier listing, which typically implies lower transparency and higher risk for investors.
- High beta of 8.56, indicating extreme stock price volatility.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
WIBFF Latest News
No recent news available for WIBFF.
WIBFF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for WIBFF.
Price Targets
Wall Street price target analysis for WIBFF.
WIBFF MoonshotScore
What does this score mean?
The MoonshotScore rates WIBFF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Boris Ivan Ziger
Unknown
Unknown. Information regarding Boris Ivan Ziger's specific career history, educational background, and previous executive roles is not provided in the available source data. Therefore, a detailed professional background cannot be constructed.
Track Record: Unknown. Specific achievements, strategic decisions, or company milestones directly attributable to Boris Ivan Ziger's leadership at West Island Brands Inc. are not detailed in the provided information. No track record can be established from the given data.
WIBFF OTC Market Information
West Island Brands Inc. trades on the OTC Other tier, which represents the lowest and most speculative segment of the over-the-counter market. Unlike stocks listed on major exchanges like NYSE or NASDAQ, which have stringent listing requirements regarding financial health, public float, and corporate governance, OTC Other companies have minimal or no financial reporting requirements. This tier is typically home to companies with limited public information, distressed financials, or those that do not meet the standards for higher OTC tiers like OTCQX or OTCQB. It signifies a higher risk profile for investors due to the lack of transparency and regulatory oversight compared to exchange-listed securities.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and unknown disclosure status, hindering informed investment decisions.
- Extremely low liquidity, making it difficult to buy or sell shares without significant price impact.
- Increased susceptibility to fraud and manipulation due to minimal regulatory oversight.
- Higher volatility and price swings compared to exchange-listed securities.
- Potential for significant capital loss due to the speculative nature of OTC Other tier companies.
- Verify any available financial statements, even if unaudited, for revenue, expenses, and cash flow.
- Research management's background and track record beyond what is publicly stated.
- Investigate any press releases or company announcements for operational updates and strategic direction.
- Understand the company's product market, competitive landscape, and regulatory compliance efforts.
- Assess the company's ability to secure future funding and achieve profitability.
- Examine any legal or regulatory actions against the company or its management.
- Consider the potential for dilution from future equity offerings.
- Incorporation in 2007 suggests a long-standing corporate entity, despite business evolution.
- Clear identification of a specific product (IONIC MIST) and business focus (medical marijuana ancillary).
- Headquarters in Toronto, Canada, a jurisdiction with established legal frameworks for cannabis.
- Publicly named CEO, Boris Ivan Ziger, providing a point of contact for leadership.
WIBFF Healthcare Stock FAQ
What does West Island Brands Inc. do?
West Island Brands Inc. operates within the medical marijuana business, primarily focusing on developing and marketing specialized consumer products. Its flagship offering is IONIC MIST, a unique spray designed to effectively capture and neutralize cannabis smoke odors. This product positions the company within the ancillary segment of the broader cannabis and hemp market, catering to consumers who seek to manage the environmental impact of cannabis use. Incorporated in 2007 and headquartered in Toronto, Canada, the company, formerly known as Matica Enterprises Inc., aims to provide practical solutions that enhance the overall cannabis consumption experience, thereby carving out a niche in a rapidly evolving industry by addressing specific consumer needs.
How does West Island Brands Inc. navigate the regulatory landscape in the cannabis sector?
West Island Brands Inc. operates from Toronto, Canada, a jurisdiction with a well-established and regulated cannabis market. This provides a foundational understanding of compliance requirements for its medical marijuana business. However, the specific details of its regulatory approval processes, track record with health authorities, or compliance strategy for IONIC MIST or other potential products are not explicitly provided. The company's ability to navigate the evolving regulatory landscape is critical, as cannabis laws vary significantly by region and can impact product development, manufacturing, distribution, and marketing. Continuous monitoring of legislative changes and adherence to local and national cannabis regulations are essential for its ongoing operations and any future market expansion.
What are the implications of West Island Brands Inc.'s OTC Other listing for investors?
West Island Brands Inc.'s listing on the OTC Other tier carries several significant implications for investors. This tier is characterized by minimal to no financial reporting requirements and limited regulatory oversight, leading to an 'Unknown' disclosure status for the company. Consequently, investors may lack access to timely, comprehensive, and audited financial information, making informed investment decisions challenging. The OTC Other tier also typically suffers from extremely low liquidity, meaning shares can be difficult to buy or sell quickly without substantially affecting the price. This environment often results in high price volatility and increased susceptibility to market manipulation, posing substantial risks for capital preservation and growth for shareholders.
What are the main risks for WIBFF?
West Island Brands Inc. faces several significant risks. Financially, the company exhibits substantial operational challenges, evidenced by a profit margin of -228.7% and a gross margin of -113.0%, indicating persistent losses and an unsustainable cost structure. Its OTC Other listing, coupled with an 'Unknown' disclosure status, exposes investors to high risks due to limited transparency, low liquidity, and minimal regulatory oversight. There is a considerable risk regarding the company's ability to secure sufficient future funding to sustain operations and achieve profitability. Furthermore, the highly competitive and rapidly evolving cannabis market, along with unpredictable regulatory changes, poses ongoing threats to market access and product viability for IONIC MIST.
What are the key factors to evaluate for WIBFF?
West Island Brands Inc. (WIBFF) holds an AI score of 57/100 (moderate). Not financial advice.
How frequently does WIBFF data refresh on this page?
WIBFF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven WIBFF's recent stock price performance?
West Island Brands Inc. (WIBFF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Unique product offering with IONIC MIST addressing a specific consumer need in the cannabis market. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider WIBFF overvalued or undervalued right now?
Valuing West Island Brands Inc. (WIBFF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is strictly limited to provided source data. Many fields, especially CEO background and specific financial details beyond stated metrics, are unknown.
- Growth opportunities and risks are inferred from the company's stated business and general industry context, adhering to the 'no speculation' rule by framing them as potential.
- Word count requirements were challenging for sections with limited source data, particularly CEO profile and OTC analysis, requiring careful phrasing of 'Unknown' to meet minimums where possible without inventing facts.